The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
- 4 December 2014
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 39 (2), 177-182
- https://doi.org/10.1016/j.leukres.2014.11.025
Abstract
No abstract availableKeywords
Funding Information
- The Netherlands Organization for Health Research and Development (152001007)
This publication has 29 references indexed in Scilit:
- Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010European Journal Of Cancer, 2014
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNetBlood, 2013
- An evolutionary perspective on chronic myelomonocytic leukemiaLeukemia, 2013
- Incidence, survival and prevalence of myeloid malignancies in EuropeEuropean Journal Of Cancer, 2012
- Myelodysplastic SyndromesJournal of the National Comprehensive Cancer Network, 2011
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsBlood, 2008
- Myelodysplastic syndromesBlood, 2008
- Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferenceLeukemia Research, 2007
- Myelodysplastic syndromesCancer, 2007